Pulmonology Advisor39 分钟
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in Type 2 Diabetes
GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.